COVID-19 antivirals: Doctors clash over PBS eligibility
![](https://www.ausdoc.com.au/wp-content/uploads/2023/02/dr_michelle_ananda_rajah_mp-300x225.jpg)
Leading doctors have clashed over eligibility criteria for COVID-19 antivirals — specifically nirmatrelvir–ritonavir — following claims many patients were being “short-changed” and left unprotected.
Federal Labor MP and infectious diseases physician Dr Michelle Ananda-Rajah said she had recently paid more than $1100 for an unspecified antiviral for a sick family member who was ineligible for a PBS-subsidised script.